🔎 Trials Near Me

Home › Kidney Diseases › Florida › Orlando

Kidney Diseases clinical trials in Orlando, FL

7 studies for Kidney Diseases are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

RecruitingPhase 3
  • CTR Oakwater, LLC, Orlando
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06963827

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 2
  • Jade Clinical Site, Orlando
Ages 18 to 60 · All sexes · Updated Sep 25, 2026 · NCT07541287

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

RecruitingPhase 3
  • Nephrology Associates Of Central FL, Orlando
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319

SPYRAL GEMINI Pilot Study

Recruiting
  • Orlando Health Heart & Vascular Institute, Orlando
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147

Study of BHV-1400 in IgA Nephropathy

RecruitingPhase 1
  • Site-013, Orlando
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

RecruitingPhase 1
  • Adia Med Of Winter Park, Winter Park · 5 mi away
Ages 18 to 80 · All sexes · Updated Jun 17, 2026 · NCT07572890

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

RecruitingPhase 3
  • CTR Oakwater LLC, Orlando
Ages 12 to 80 · All sexes · Updated Feb 3, 2026 · NCT05183646

About Kidney Diseases

Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.

More about Kidney Diseases on MedlinePlus

Kidney Diseases trials in other cities

Other studies in Orlando

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.